Stephanie Ortiz-Collazos, Ariane J. Sousa-Batista, Tiago A. Balbino
{"title":"Engineering microfluidic devices to mimic signaling cascades in continuous-flow cell culture as multiorgan microphysiological systems","authors":"Stephanie Ortiz-Collazos, Ariane J. Sousa-Batista, Tiago A. Balbino","doi":"10.1016/j.bej.2024.109475","DOIUrl":null,"url":null,"abstract":"<div><p>The inability of traditional pre-clinical cell culture and animal models to accurately replicate human diseases and drug toxicities leads to a significant halt in the advancement of effective treatment strategies, in addition to financial losses. This, combined with the rise in ethical concerns about animal welfare, highlights the need for alternative and more realistic representations of human physiology. Microfluidics-based multiorgan microphysiological systems present a promising avenue for studying human body homeostasis, and have the potential to revolutionize translational research by creating new opportunities to comprehend systemic diseases and develop personalized medicine. In this review, we describe important design and operational considerations for engineering microfluidic devices mimicking tissue/organ “cross-talk” for <em>in vitro</em> drug disposition and safety assessments, as well as in disease modeling. We conducted a meticulous analysis of relevant articles and calculated crucial parameters, like the Reynolds number and shear stress, to compare the operational characteristics of different microfluidic devices. Additionally, we provide the reader with perspectives on the current limitations, insights to address the pending issues, and describe future opportunities of these technologies in the clinical setting.</p></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"211 ","pages":"Article 109475"},"PeriodicalIF":3.7000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X24002626","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The inability of traditional pre-clinical cell culture and animal models to accurately replicate human diseases and drug toxicities leads to a significant halt in the advancement of effective treatment strategies, in addition to financial losses. This, combined with the rise in ethical concerns about animal welfare, highlights the need for alternative and more realistic representations of human physiology. Microfluidics-based multiorgan microphysiological systems present a promising avenue for studying human body homeostasis, and have the potential to revolutionize translational research by creating new opportunities to comprehend systemic diseases and develop personalized medicine. In this review, we describe important design and operational considerations for engineering microfluidic devices mimicking tissue/organ “cross-talk” for in vitro drug disposition and safety assessments, as well as in disease modeling. We conducted a meticulous analysis of relevant articles and calculated crucial parameters, like the Reynolds number and shear stress, to compare the operational characteristics of different microfluidic devices. Additionally, we provide the reader with perspectives on the current limitations, insights to address the pending issues, and describe future opportunities of these technologies in the clinical setting.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.